Publication date: Available online 17 November 2026 Source: Molecular Therapy Oncology Author(s): Harrison B. Konsker, Huibin Tang, Eva L. Matentsian, Rachel Z. Tao, Shuhuan Fang, Bella Rivera, Myung Lee, Syed Saadan Ahmed, Hao He, Ntemena Kapula, Ryan Randle, Jake J. Kim, Devanish N. Kamtam, Brandon Guenthart, Natalie Lui, Irmina A. Elliott, Joseph B. Shrager
Selective Inhibition of EGFR-mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002626?dgcid=rss_sd_all
Selective Inhibition of EGFR-mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002626?dgcid=rss_sd_all
“Selective Inhibition of EGFR-mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting.” Molecular Therapy: Oncology.
@article{article94760,
title = {Selective Inhibition of EGFR-mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002626?dgcid=rss_sd_all}
}